98%
921
2 minutes
20
Background And Objectives: C3 glomerulopathy and idiopathic Ig-associated membranoproliferative GN are kidney diseases characterized by abnormal glomerular complement C3 deposition. These conditions are heterogeneous in outcome, but approximately 50% of patients develop kidney failure within 10 years.
Design, Setting, Participants, & Measurements: To improve identification of patients with poor prognosis, we performed a detailed analysis of percutaneous kidney biopsies in a large cohort of patients. Using a validated histologic scoring system, we analyzed 156 native diagnostic kidney biopsies from a retrospective cohort of 123 patients with C3 glomerulopathy and 33 patients with Ig-associated membranoproliferative GN. We used linear regression, survival analysis, and Cox proportional hazards models to assess the relationship between histologic and clinical parameters with outcome.
Results: Frequent biopsy features were mesangial expansion and hypercellularity, glomerular basement membrane double contours, and endocapillary hypercellularity. Multivariable analysis showed negative associations between eGFR and crescents, interstitial inflammation, and interstitial fibrosis/tubular atrophy. Proteinuria positively associated with endocapillary hypercellularity and glomerular basement membrane double contours. Analysis of second native biopsies did not demonstrate associations between immunosuppression treatment and improvement in histology. Using a composite outcome, risk of progression to kidney failure associated with eGFR and proteinuria at the time of biopsy, cellular/fibrocellular crescents, segmental sclerosis, and interstitial fibrosis/tubular atrophy scores.
Conclusions: Our detailed assessment of kidney biopsy data indicated that cellular/fibrocellular crescents and interstitial fibrosis/tubular atrophy scores were significant determinants of deterioration in kidney function.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269630 | PMC |
http://dx.doi.org/10.2215/CJN.16801221 | DOI Listing |
J Bras Nefrol
August 2025
Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.
Introduction: Glomerular diseases (GD) are an important cause of chronic kidney disease (CKD). This study aims to analyze the socio-demographic, clinical, and renal outcome profiles of patients with GD.
Methods: A retrospective cohort study was conducted between 1998 and 2023.
Kidney Int Rep
August 2025
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Introduction: Rituximab (RTX) therapy has become the standard of care for treatment of membranous nephropathy (MN). However, data on hard outcomes such as end-stage kidney disease (ESKD) and loss of estimated glomerular filtration rate (eGFR), are lacking.
Methods: This was a retrospective study on all patients with MN treated with RTX between January 2000 and December 2022.
Transplant Direct
May 2025
Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Background: Donor-derived cell-free DNA (dd-cfDNA) is an emerging biomarker of kidney allograft injury, mainly investigated in the context of rejection. However, the dd-cfDNA dynamics in other graft pathologies merit further investigation.
Methods: In this single-center observational study, we prospectively collected dd-cfDNA at indication biopsies.
Kidney360
July 2025
Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Background: Foot process effacement (FPE), a marker of podocyte injury observable via electron microscopy (EM), plays a key role in the pathophysiology of albuminuria and kidney disease progression. Whether FPE, as reported on kidney biopsies, is associated with histopathologic lesions and adverse clinical outcomes across a range of kidney diseases has not yet been explored.
Methods: We developed semi-quantitative scores from free text pathologists' descriptions of FPE severity, using EM reports from 813 participants in the Boston Kidney Biopsy Cohort (BKBC), a prospective cohort study of individuals with biopsy-confirmed kidney disease.
Indian J Pathol Microbiol
June 2025
Department of Nephrology, Christian Medical College, Vellore, Tamil Nadu, India.
Objectives: 1) To perform a retrospective histological evaluation of renal allograft biopsies diagnosed as recurrent/denovo IgA nephropathy from January 2011 to January 2019 and calculate individual MESTC scores and Banff scores for all cases. 2) To perform clinicopathological and statistical evaluation of histological variables of the updated oxford scoring system with variables of estimated glomerular filtration rate, proteinuria, and serum creatinine, recorded at the time of the last follow-up.
Materials And Methods: This was a retrospective cohort study conducted at a tertiary hospital.